Exploring Cyclooxygenase-2 (COX-2) Inhibitors From Ascidian Derived Ligands For Cancer Treatment: An In-Silico Study. . CDF. 2025;54(2):3320-3333. doi:10.48047/CU/54/02/3320-3333